Ben Sasse (R–Neb.), who previously served as president of the University of Florida, revealed in late December that he had ...

New mRNA vaccines could be a critical tool to fight cancer. But their future is up in the air - More than 626,000 Americans ...

The global immuno-oncology drugs market is expanding rapidly due to rising cancer prevalence and sustained clinical benefits.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

With the introduction of mRNA vaccines in the 2010s – vaccines that use messenger RNA molecules in cells to train the body to ...

An mRNA vaccine for pancreatic cancer is showing long-term results in an early-stage clinical trial.  Still in its ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...

Jazz Pharma's Ziihera and Eli Lilly's Jaypirca, respectively – have been recommended by reimbursement agency NICE for NHS use ...

The phase 3 LITESPARK-012 trial is testing triplet therapy with oral HIF-2 alpha inhibitor Welireg (belzutifan) given ...

The cancer antigen therapy mRNA-4359 yielded a high rate of antitumor responses in combination with pembrolizumab (Keytruda) ...

A key protein, HOXD13, helps melanoma tumors grow and evade the immune system by boosting blood supply and blocking cancer-fighting T cells. Disabling it shrinks tumors and reopens the door for the ...